Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ALEC — Alector, Inc.

CIK 1167557 Greenwich, CT
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,632,247
+$1,102,882 QoQ
Shares Held
1,309,577
+84.1% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 140 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ALEC ranks #113 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ALEC

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,632,247 1,309,577
2026-03-31 $1,529,365 711,334
2025-12-31 $935,326 599,569
2025-09-30 $1,296,736 438,087
2025-06-30 $569,264 406,618
2025-03-31 $605,886 492,592
2024-12-31 $1,063,948 562,936
2024-09-30 $969,283 208,001
2024-06-30 $837,678 184,511
2024-03-31 $1,145,063 190,210
2023-12-31 $524,022 65,667
2023-09-30 $413,404 63,797
2023-06-30 $145,448 24,201
2023-03-31 $466,348 75,339
2022-12-31 $1,658,335 179,668
2022-09-30 $6,206,024 656,028
2022-06-30 $3,581,714 352,531
2022-03-31 $2,369,604 166,288
2021-12-31 $1,870,394 90,576
2021-09-30 $788,179 34,539
2020-09-30 $167,833 15,931